2012 annual financial data
Xenon Pharmaceuticals 2012 Operating margin
Direct answer
Operating margin was -22.04%.
Operating income was -3,153,000 USD and net income was -4,301,000 USD.
Operating cash flow was 45,573,000 USD.
Get free Xenon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,308,000 USD
- Operating income
- -3,153,000 USD
- Net income
- -4,301,000 USD
- Operating cash flow
- 45,573,000 USD